Press release
NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market || Key Players: Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.
According to the latest report by Fact.MR, the preimplantation genetic testing market is expected to experience strong growth. The preimplantation genetic testing market is estimated to reach US$ 575.0 million revenue by 2022 end. Due to the increasing awareness of preimplantation genetic testing to avoid genetic disorders, the rise in a number of healthcare providers and healthcare institutes providing preimplantation genetic testing are the influencing factors contributing to growth of preimplantation genetic testing market.Preimplantation genetic testing is done to find out specific genetic diseases within embryos. This testing is gaining lot of traction due to the increased risk of various diseases owing to the changing lifestyle. Various healthcare institutes, healthcare providers, and researchers are continuously researching on the preimplantation genetic testing to find new methods to eliminate various risks involved in preimplantation genetic diagnosis.
The preimplantation genetic testing market is likely to witness steady growth over the course of the forecast period. Preimplantation genetic testing is the procedure of testing embryos to identify genetic diseases or defects before implantation. Along with implantation of healthy embryo which results in the genetically healthy baby, the preimplantation genetic testing is done to eliminate the risk of structural chromosome abnormalities, Mendelian disorders, etc.
Request Sample here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=292
Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth in preimplantation genetic testing market.
Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy
Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.
Browse Full Report on Preimplantation Genetic Testing Market with TOC-
https://www.factmr.com/report/292/preimplantation-genetic-testing-market
North America is likely to emerge as the biggest market in the global preimplantation genetic testing. North America preimplantation genetic testing market is projected to surpass US$ 200 million by the end of 2022. Increasing adoption of innovative technologies and rising awareness about preimplantation genetic testing to avoid various birth defects among babies are some of the factors fueling the market growth in the region.
Europe is expected to be the second most lucrative market for preimplantation genetic testing. Owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government is driving the growth of preimplantation genetic testing in Europe.
Research Methodology
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include, Primary research Secondary research Trade research Focused interviews Social media analysis
Competition Tracking
The report also profiles companies operating in the preimplantation genetic testing market, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.
For More Information Raise Enquiry Here:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=292
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market || Key Players: Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation. here
News-ID: 1712891 • Views: …
More Releases from Fact.MR
Softgels Dietary Supplements - Top Global Industry Trends in 2026
The global softgels dietary supplements market is set to witness significant expansion in 2026, driven by rising health consciousness, the shift toward preventive healthcare, and increasing consumer preference for easy-to-swallow, highly bioavailable supplement formats. Softgels, known for their superior absorption properties and compatibility with both lipophilic and sensitive active ingredients, continue to gain strong traction among nutraceutical brands and consumers worldwide.
This press release provides a comprehensive outlook on market size…
European Automotive Steering System Market Outlook 2025-2035: Key Developments a …
The European automotive steering system market is positioned for steady advancement from 2025 to 2035, driven by accelerating vehicle electrification, rising consumer demand for comfort and safety, and continuous innovations in chassis and mobility technologies. Steering systems-including hydraulic power steering (HPS), electro-hydraulic power steering (EHPS), electric power steering (EPS), steer-by-wire technology, and associated components-play a crucial role in determining vehicle handling, stability, and driver experience. This report highlights market size…
European Automotive Human Machine Interface Market Outlook 2025-2035: Key Develo …
The European automotive human machine interface (HMI) market is set for significant advancement from 2025 to 2035, driven by rapid digitalization in vehicles, rising consumer expectations for intelligent in-car experiences, and accelerated adoption of advanced driver-assistance systems (ADAS). Automotive HMIs-including touchscreens, gesture control systems, voice recognition platforms, heads-up displays (HUDs), haptic feedback modules, and connected infotainment systems-are becoming central to modern vehicle design, enhancing safety, comfort, and interactivity. This report…
European Vehicle Anti-theft System Market Outlook 2025-2035: Key Developments an …
The European vehicle anti-theft system market is entering a transformative decade from 2025 to 2035, supported by rising vehicle crime rates, technological advancements in automotive security, and expanding adoption of connected and smart mobility solutions. Vehicle anti-theft systems-including immobilizers, alarms, keyless entry systems, steering locks, biometric access solutions, GPS-based tracking modules, and advanced telematics platforms-are becoming indispensable components for safeguarding passenger cars, commercial vehicles, and luxury fleets across Europe. This…
More Releases for Preimplantation
Preimplantation Genetic Testing Market Scope & Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Preimplantation Genetic Testing Market size was valued at USD 467.52 Million in 2020 and is projected to reach USD 995.76 Million by 2028, growing at a CAGR of 10.01% from 2021 to 2028.
The growth of the Preimplantation Genetic Testing (PGT) market is driven by several key factors. The increasing prevalence of genetic disorders and chromosomal abnormalities has significantly heightened the demand for advanced diagnostic techniques such as…
Preimplantation Genetic Testing Market worth $1.2 billion by 2028
Preimplantation Genetic Testing Market in terms of revenue was estimated to be worth $0.7 billion in 2023 and is poised to reach $1.2 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the high risk of chromosomal abnormalities with advancing maternal age, and the rising number of fertility clinics. Furthermore,…
Preimplantation Genetic Testing Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Preimplantation Genetic Testing (PGT) (PGS/PGD) Market will expand with a CAGR value of 6.2 percent from 2021 to 2026. Because of the growing incidence of genetic, inherited, and chromosomal disorders, the global PGT industry is projected to expand significantly during the projected timeline.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-preimplantation-genetic-testing-pgt-market-3112
By PGD/PGS (Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS)), By Type (Chromosomal Abnormalities, X-linked…
Preimplantation Genetic Diagnosis Market| Key Players - Genesis Genetics, Genea …
As per the current market trends and the promising nature of the Preimplantation Genetic Diagnosis market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Market Research Reports Search Engine would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode various…
Preimplantation Genetic Diagnosis Market Opportunity Analysis, 2018-2026
Preimplantation genetic diagnosis (PGD) is the genetic profiling of the pre implantable embryos and oocytes before their implantation. The preimplantation genetic diagnosis is similar to that of the parental diagnosis in case of screening for a particular genetic disease. The PGD is advantageous in a way that it helps to avoid the selective pregnancy termination by development and growth of healthy fetus. PGD serves as an addendum to assisted reproductive…
Global Preimplantation Genetic Diagnosis Sales Market Report 2021
Global Preimplantation Genetic Diagnosis Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The report provides a holistic overview of the global Preimplantation Genetic Diagnosis market. It studies the market’s trajectory between 2016 and 2021. Compiling various factors encouraging the market and relevant data summarizing the market’s trajectory in the past few years, the report makes for a guidebook for…
